Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19330599rdf:typepubmed:Citationlld:pubmed
pubmed-article:19330599lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19330599lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:19330599lifeskim:mentionsumls-concept:C0252528lld:lifeskim
pubmed-article:19330599lifeskim:mentionsumls-concept:C0428883lld:lifeskim
pubmed-article:19330599lifeskim:mentionsumls-concept:C1416830lld:lifeskim
pubmed-article:19330599lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:19330599lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:19330599pubmed:issue2lld:pubmed
pubmed-article:19330599pubmed:dateCreated2009-3-30lld:pubmed
pubmed-article:19330599pubmed:abstractTextThe galectin-2 (LGALS2) 3279 C/T single nucleotide polymorphism (SNP) has recently been associated with myocardial infarction (MI). Although hypertension, a very prevalent entity in rheumatoid arthritis (RA), is one of the greatest risk factors for MI, the possible association of LGALS2 3279 C/T and hypertension has not been investigated. We genotyped 386 RA patients, 272 hypertensives and 114 normotensives. Diastolic blood pressure (DBP) was significantly lower in TT compared to CC homozygotes (-4.11 mmHg, p = 0.044) even when adjusted for multiple confounders (-4.28 mmHg, p = 033). Further studies are required to replicate the potential association of LGALS2 3279 C/T with DBP, and examine whether this SNP could be used as a marker of increased risk for future cardiovascular events in RA populations.lld:pubmed
pubmed-article:19330599pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19330599pubmed:languageenglld:pubmed
pubmed-article:19330599pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19330599pubmed:citationSubsetIMlld:pubmed
pubmed-article:19330599pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19330599pubmed:statusMEDLINElld:pubmed
pubmed-article:19330599pubmed:monthAprlld:pubmed
pubmed-article:19330599pubmed:issn1525-6006lld:pubmed
pubmed-article:19330599pubmed:authorpubmed-author:NightingalePe...lld:pubmed
pubmed-article:19330599pubmed:authorpubmed-author:ElisafMoses...lld:pubmed
pubmed-article:19330599pubmed:authorpubmed-author:KitasGeorge...lld:pubmed
pubmed-article:19330599pubmed:authorpubmed-author:DouglasKaren...lld:pubmed
pubmed-article:19330599pubmed:authorpubmed-author:PanoulasVasil...lld:pubmed
pubmed-article:19330599pubmed:authorpubmed-author:SmithJacqueli...lld:pubmed
pubmed-article:19330599pubmed:authorpubmed-author:MetsiosGeorgi...lld:pubmed
pubmed-article:19330599pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19330599pubmed:volume31lld:pubmed
pubmed-article:19330599pubmed:ownerNLMlld:pubmed
pubmed-article:19330599pubmed:authorsCompleteYlld:pubmed
pubmed-article:19330599pubmed:pagination93-104lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:meshHeadingpubmed-meshheading:19330599...lld:pubmed
pubmed-article:19330599pubmed:year2009lld:pubmed
pubmed-article:19330599pubmed:articleTitleGalectin-2 (LGALS2) 3279C/T polymorphism may be independently associated with diastolic blood pressure in patients with rheumatoid arthritis.lld:pubmed
pubmed-article:19330599pubmed:affiliationDepartment of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, West Midlands, UK. bpanoulas@googlemail.comlld:pubmed
pubmed-article:19330599pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19330599pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3957entrezgene:pubmedpubmed-article:19330599lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19330599lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19330599lld:entrezgene